Next Article in Journal
Developing a Glyoxal-Crosslinked Chitosan/Gelatin Hydrogel for Sustained Release of Human Platelet Lysate to Promote Tissue Regeneration
Next Article in Special Issue
The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H2S) Delivery Molecule AP39 Induces Brain Tolerance to Ischemia
Previous Article in Journal
Regulatory SNPs: Altered Transcription Factor Binding Sites Implicated in Complex Traits and Diseases
Previous Article in Special Issue
Carbon Monoxide and Nitric Oxide as Examples of the Youngest Class of Transmitters
Review

Hydrogen Sulfide Metabolite, Sodium Thiosulfate: Clinical Applications and Underlying Molecular Mechanisms

1
Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
2
London Health Sciences Center, Multi-Organ Transplant Program, Western University, London, ON N6A 5A5, Canada
3
London Health Sciences Center, Department of Surgery, Division of Urology, Western University, London, ON N6A 5A5, Canada
4
Department of Microbiology & Immunology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A 3K7, Canada
*
Author to whom correspondence should be addressed.
Academic Editor: Marcin Magierowski
Int. J. Mol. Sci. 2021, 22(12), 6452; https://doi.org/10.3390/ijms22126452
Received: 28 May 2021 / Revised: 10 June 2021 / Accepted: 11 June 2021 / Published: 16 June 2021
Thiosulfate in the form of sodium thiosulfate (STS) is a major oxidation product of hydrogen sulfide (H2S), an endogenous signaling molecule and the third member of the gasotransmitter family. STS is currently used in the clinical treatment of acute cyanide poisoning, cisplatin toxicities in cancer therapy, and calciphylaxis in dialysis patients. Burgeoning evidence show that STS has antioxidant and anti-inflammatory properties, making it a potential therapeutic candidate molecule that can target multiple molecular pathways in various diseases and drug-induced toxicities. This review discusses the biochemical and molecular pathways in the generation of STS from H2S, its clinical usefulness, and potential clinical applications, as well as the molecular mechanisms underlying these clinical applications and a future perspective in kidney transplantation. View Full-Text
Keywords: sodium thiosulfate (STS); thiosulfate; hydrogen sulfide (H2S); ischemia–reperfusion injury (IRI); sulfide oxidation pathway sodium thiosulfate (STS); thiosulfate; hydrogen sulfide (H2S); ischemia–reperfusion injury (IRI); sulfide oxidation pathway
Show Figures

Figure 1

MDPI and ACS Style

Zhang, M.Y.; Dugbartey, G.J.; Juriasingani, S.; Sener, A. Hydrogen Sulfide Metabolite, Sodium Thiosulfate: Clinical Applications and Underlying Molecular Mechanisms. Int. J. Mol. Sci. 2021, 22, 6452. https://doi.org/10.3390/ijms22126452

AMA Style

Zhang MY, Dugbartey GJ, Juriasingani S, Sener A. Hydrogen Sulfide Metabolite, Sodium Thiosulfate: Clinical Applications and Underlying Molecular Mechanisms. International Journal of Molecular Sciences. 2021; 22(12):6452. https://doi.org/10.3390/ijms22126452

Chicago/Turabian Style

Zhang, Max Y., George J. Dugbartey, Smriti Juriasingani, and Alp Sener. 2021. "Hydrogen Sulfide Metabolite, Sodium Thiosulfate: Clinical Applications and Underlying Molecular Mechanisms" International Journal of Molecular Sciences 22, no. 12: 6452. https://doi.org/10.3390/ijms22126452

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop